South Korea: Large Number Of mRNA Vaccine Manufacturers Being Set Up

As mRNA (messenger ribonucleic acid) emerges as a new paradigm for vaccines, a large number of pharmaceutical bio companies have decided to partner with the South Korean government. However, as per reports, companies have been criticised to use this opportunity to gain profit. According to an official, "there are companies planning to gain profits from the mRNA trend without a clear roadmap." "Government will be verifying," he added